DIMENSIONAL FUND ADVISORS LP - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 103 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.90 and the average weighting 0.2%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$363,091
+50611.0%
404,820
-33.3%
0.00%
Q4 2022$716
-100.0%
606,488
-8.4%
0.00%
-100.0%
Q3 2022$4,988,000
+47.3%
662,369
+23.2%
0.00%
+100.0%
Q2 2022$3,387,000
+5.2%
537,615
+38.6%
0.00%0.0%
Q1 2022$3,221,000
+117.2%
387,791
+35.8%
0.00%
Q4 2021$1,483,000
+5.3%
285,638
+35.4%
0.00%
Q3 2021$1,409,000
-11.9%
210,933
+12.4%
0.00%
-100.0%
Q2 2021$1,599,000
+9.8%
187,669
+13.9%
0.00%
Q1 2021$1,456,000
+9.5%
164,740
+52.2%
0.00%
Q4 2020$1,330,000
+66.7%
108,210
+10.4%
0.00%
Q3 2020$798,000
-15.2%
97,9810.0%0.00%
Q2 2020$941,000
+81.3%
97,981
+28.4%
0.00%
Q1 2020$519,000
+22.4%
76,296
+167.8%
0.00%
Q4 2019$424,000
+122.0%
28,488
+52.7%
0.00%
Q3 2019$191,000
-3.5%
18,653
+0.1%
0.00%
Q2 2019$198,000
-24.1%
18,6350.0%0.00%
Q1 2019$261,000
-30.0%
18,635
-49.3%
0.00%
Q4 2018$373,000
+92.3%
36,750
+127.9%
0.00%
Q3 2018$194,00016,1250.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 135,848$2,024,0006.74%
INTERWEST VENTURE MANAGEMENT CO 764,918$11,397,0004.91%
Knoll Capital Management, LLC 350,238$5,219,0003.85%
683 Capital Management, LLC 1,850,000$27,565,0003.15%
Soleus Capital Management, L.P. 205,407$3,060,0002.95%
Broadfin Capital, LLC 1,236,368$18,422,0002.47%
P.A.W. CAPITAL CORP 144,000$2,146,0002.29%
MANGROVE PARTNERS IM, LLC 847,284$12,625,0001.85%
Corriente Advisors, LLC 203,898$3,038,0001.63%
Trellus Management Company, LLC 63,850$951,0001.59%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders